DAPK
DAPK (death-associated protein kinase) is a positive mediator of gamma-interferon induced programmed cell death.
Products Related to DAPK(10)
- GC34557DIM-C-pPhCO2MeCAS: 151358-48-4Purity: >99.50%
DIM-C-pPhCO2Me is a nuclear receptor 4A1 (NR4A1) antagonist, with a K i value of 0.25μM.
- GC61593DAPK Substrate Peptide TFAPurity: >99.00%
DAPK Substrate Peptide TFA is a synthetic peptide substrate for death associated protein kinase (DAPK), with a Km of 9 μM.
- GC65140DRAK2-IN-1CAS: 871837-60-4Purity: >99.50%
DRAK2-IN-1, compound 16, is a potent, selective and ATP-competitive DRAK2 inhibitor with IC50and Kivalues of 3 nM and 0.26 nM, respectively.
- GC65328TNIK-IN-3CAS: 2754265-25-1Purity: >99.00%
TNIK-IN-3 is a potent, selective and orally active inhibitor of Traf2- and Nck-interacting protein kinase (TNIK), with an IC50 of 0.026 μM. TNIK-IN-3 could also inhibit Flt4 (IC50=0.030 μM), Flt1 (IC50=0.191 μM) and DRAK1 (IC50=0.411 μM). TNIK-IN-3 can be used for the research of colorectal cancer.
- GC80881PROTAC DAPK1 Degrader-1CAS: 3063030-38-3Purity: >96.50%
PROTAC DAPK1 Degrader-1 is a death-associated protein kinase 1 (DAPK1) degrader with a DC 50 of 119.6 nM.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC13950 | TC-DAPK 6 | 315694-89-4 | >98% | |
| GC34557 | DIM-C-pPhCO2Me | 151358-48-4 | >99.50% | |
DIM-C-pPhCO2Me is a nuclear receptor 4A1 (NR4A1) antagonist, with a K i value of 0.25μM. | ||||
| GC50260 | HS 38 | 1030203-81-6 | >99.00% | |
ATP-competitive inhibitor of DAPK and ZIPK | ||||
| GC61593 | DAPK Substrate Peptide TFA | - | >99.00% | |
DAPK Substrate Peptide TFA is a synthetic peptide substrate for death associated protein kinase (DAPK), with a Km of 9 μM. | ||||
| GC65140 | DRAK2-IN-1 | 871837-60-4 | >99.50% | |
DRAK2-IN-1, compound 16, is a potent, selective and ATP-competitive DRAK2 inhibitor with IC50and Kivalues of 3 nM and 0.26 nM, respectively. | ||||
| GC65328 | TNIK-IN-3 | 2754265-25-1 | >99.00% | |
TNIK-IN-3 is a potent, selective and orally active inhibitor of Traf2- and Nck-interacting protein kinase (TNIK), with an IC50 of 0.026 μM. TNIK-IN-3 could also inhibit Flt4 (IC50=0.030 μM), Flt1 (IC50=0.191 μM) and DRAK1 (IC50=0.411 μM). TNIK-IN-3 can be used for the research of colorectal cancer. | ||||
| GC72879 | HS148 | 1892595-16-2 | >95.00% | |
HS148 (compound 22) is a selective DAPK3 inhibitor with an Ki value of 119 nM. | ||||
| GC73211 | CK156 | 2910938-59-7 | >99.50% | |
CK156 is a highly selective death-associated protein kinase (DAPK) inhibitor with IC50s of 182 nM,34 μM, and 39 μM in the DRAK1 NanoBRET assay for DRAK1, CK2a1, and CK2a2, respectively. | ||||
| GC80881 | PROTAC DAPK1 Degrader-1 | 3063030-38-3 | >96.50% | |
PROTAC DAPK1 Degrader-1 is a death-associated protein kinase 1 (DAPK1) degrader with a DC 50 of 119.6 nM. | ||||
| GC81304 | GW296115 | 118458-58-5 | >98.50% | |
GW296115 is a multi-target inhibitor with the following IC 50 values against its targets: 8.4 nM for BRSK2, 21 nM for BRSK1, 1.8 μM for PDGFRβ, 5.5 nM for STK17B/DRAK2, 28 nM for DRAK1, 20 nM for PHKG1, and 89 nM for DCAMKL3. | ||||
